Advertisement

Topics

Bronstein, Gewirtz & Grossman, LLC Company Profile

13:20 EDT 22nd June 2018 | BioPortfolio


News Articles [26 Associated News Articles listed on BioPortfolio]

Bronstein, Gewirtz and Grossman, LLC: SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Continues Investigation of Intel Corporation (INTC)

NEW YORK, NY / ACCESSWIRE / January 8, 2018 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Intel Corporation ("Intel" or the "Company") (NASDAQ: I...

Bronstein, Gewirtz and Grossman, LLC: SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Johnson & Johnson (JNJ) & Lead Plaintiff Deadline - April 9, 2018

NEW YORK, NY / ACCESSWIRE / February 13, 2018 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Johnson & Johnson ("J&J" or the "Company") (...

Bronstein, Gewirtz and Grossman, LLC: SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Bellicum Pharmaceuticals, Inc. (BLCM) & Lead Plaintiff Deadline: April 9, 2018

NEW YORK, NY / ACCESSWIRE / March 19, 2018 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Bellicum Pharmaceuticals, Inc. ("Bellicum" or th...

Bronstein, Gewirtz and Grossman, LLC: FINAL SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Acorda Therapeutics, Inc. (ACOR) and Lead Plaintiff Deadline: January 17, 2018

NEW YORK, NY / ACCESSWIRE / January 17, 2018 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Acorda Therapeutics, Inc. ("Acorda" or the "C...

Bronstein, Gewirtz and Grossman, LLC: DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Array Biopharma, Inc. (ARRY) & Lead Plaintiff Deadline - January 22, 2018

NEW YORK, NY / ACCESSWIRE / January 18, 2018 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Array Biopharma, Inc. ("Array" or the "Company...

SHAREHOLDER ALERT: Bronstein, Gewirtz Grossman, LLC Announces Investigation of Kulicke and ...

On May 10, 2018, Kulicke and Soffa announced that it would delay filing its Quarterly Report on Form 10-Q with the Securities and Exchange Read more...

SHAREHOLDER ALERT: Bronstein, Gewirtz Grossman, LLC Announces Investigation of Proteostasis ...

On March 20, 2018, Kerrisdale Capital Management published a report entitled "Proteostasis Therapeutics, Inc.: Hyped-Up Lung Data? Just a Lot of Hot Air."  The Read more...

SHAREHOLDER ALERT: Bronstein, Gewirtz Grossman, LLC Announces Investigation of Symantec ...

On May 10, 2018, after the market closed, Symantec disclosed that its Audit Committee had commenced an investigation "in connection with concerns raised by Read more...

Drugs and Medications [0 Results]

None

PubMed Articles [5 Associated PubMed Articles listed on BioPortfolio]

Testing the Grossman model of medical spending determinants with macroeconomic panel data.

Michael Grossman's human capital model of the demand for health has been argued to be one of the major achievements in theoretical health economics. Attempts to test this model empirically have been s...

Herman Grossman, MD, MS (1924-2018).

Bond with Me If You Can! Natural Product, Covalent Ligand, and Reactivity-Based Probe Compete for Cysteine in PP2A Complex.

In this issue of Cell Chemical Biology, Grossman et al. (2017) disclose a chemoproteomics-enabled strategy to identify the cysteine-reactive target(s) of the anti-cancer natural product withaferin A ...

From appetite setpoint to appetition: 50years of ingestive behavior research.

I review the main themes of my 50-year research career in ingestive behavior as a graduate student at the University of Chicago and a professor at the City University of New York. A seminar course wit...

Reverting the molecular fingerprint of tumor dormancy as a therapeutic strategy for glioblastoma.

Glioblastoma is an aggressive and invasive brain malignancy with high mortality rates despite current treatment modalities. In this study, we show that a 7-gene signature, previously found to govern t...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma

A recent prospective multicenter study by Dr. Grossman demonstrated that 40% of patients with high grade glioma undergoing radiation and chemotherapy developed severe and persistent lympho...

Mindful Meditation for Chronic Stroke

Falls have significant consequences for older adults, including fracture, disability, and death (1). Risk factors for falls include both impaired physical and cognitive function (1). Thus,...

Cardiac and Skeletal Muscle Energy Metabolism in Abnormal Growth Hormone States

Growth hormone (GH) is important for growth in childhood, but also has important effects on a number of tissues throughout life. GH deficiency and GH excess (acromegaly, caused by a pituit...

Companies [9 Associated Companies listed on BioPortfolio]

Bronstein, Gewirtz & Grossman, LLC

Grossman Burn Center

Founded in 1969 by Dr. A. Richard Grossman and now under the direction of Dr. Peter H. Grossman, M.D., FACS, the Grossman Burn Center is renowned for its expertise in providing ac...

Grossman Burn Centers

The Grossman Burn Centers provide acute and reconstructive burn care, rehabilitation and post-treatment emotional and psychological support. For more information: www.grossmanburn...

Dr. Melanie Grossman

Dr. Melanie Grossman is a leading Harvard trained, board certified cosmetic and laser dermatologist, renowned globally as a pioneer of laser science. Her private practice on Madison Avenue in NYC off...

The Grossman Burn Centers

The Grossman Burn Centers are renowned for their expertise in establishing plastic surgery-based burn units within existing hospitals that lack burn care resources and infrastruct...

More Information about "Bronstein, Gewirtz & Grossman, LLC" on BioPortfolio

We have published hundreds of Bronstein, Gewirtz & Grossman, LLC news stories on BioPortfolio along with dozens of Bronstein, Gewirtz & Grossman, LLC Clinical Trials and PubMed Articles about Bronstein, Gewirtz & Grossman, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bronstein, Gewirtz & Grossman, LLC Companies in our database. You can also find out about relevant Bronstein, Gewirtz & Grossman, LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record